crypto is not a currency, Top stories

South Korean banks' net household loans increased by 1.9 trillion won in October.The CSI A500ETF paid dividends for the first time. On December 11th, ICBC Credit Suisse announced the dividend, becoming the first CSI A500ETF product to announce the dividend. The dividend plan is to allocate 0.066 yuan for every 10 fund shares, the base date of income distribution is November 29, and the net value of fund shares on the base date is 1.0078 yuan. In addition, ICBC Credit Suisse CSI A500ETF's dividend registration date is December 13th, and the cash dividend payment date is December 18th.Xinshida Inverter has successfully obtained the type approval certificate of China Classification Society. Recently, Xinshida Inverter AS710M has successfully obtained the type approval certificate issued by China Classification Society (CCS), which indicates that Xinshida Electric's products meet the strict standards of the international shipping industry, and also indicates that the company will further expand its market share in the field of ship and ocean engineering.

Yanshan Technology has set up a new subsidiary in Shanghai. According to the enterprise search APP, Shanghai Yunsong Technology Co., Ltd. was recently established with Zhang Weiming as the legal representative and a registered capital of 10 million yuan. Its business scope includes technical services, technical development, technical consultation, technical exchange, technology transfer and technology promotion. Enterprise equity penetration shows that the company is wholly owned by Yanshan Technology.The founder of Zhou Heiya responded that he was injured: Everyone must buy a regular brand in a regular place. On December 10th, Zhou Fuyu, the founder of Zhou Heiya, sent a video saying that he was injured in an explosion while boiling water in an outdoor magnetic furnace a few days ago, and then went to the hospital for treatment. He also thanked the netizens for their concern. He said in the video that he hopes to arouse everyone's vigilance and attention, and it may be safer to buy a regular brand of magnetic furnace in a regular place.Baoxin software: Baokang electronic Beidou vehicle-mounted positioning terminal has achieved a substantial breakthrough in Beidou application through the certification of the Third Institute of Public Security. Recently, the Beidou vehicle-mounted positioning terminal independently integrated by Baoxin software Baokang Electronics has passed the authoritative certification of the Third Institute of Public Security. The terminal adopts a fully domestic chip, which indicates that Baokang Electronics has made a substantial breakthrough in the Beidou application field and has taken a solid step to expand into new business fields. The terminal is based on a single Beidou chip, and all components are made in China, which can achieve centimeter-level accurate positioning. It has a wide application potential in many fields, such as official vehicle management, iron ore transport vehicle scheduling, steel coil frame transport vehicle positioning, fully automatic torpedo tank car positioning, electric bicycle management and so on.

By 10:56, 100 stocks in the two cities had daily limit.South Korea's former defense minister attempted to commit suicide in prison, and the Ministry of Justice responded that his physical condition was normal. According to Yonhap News Agency's report on the 11th, South Korea's former defense minister Jin Longxian attempted suicide in prison on the evening of 10th. In this regard, Shen Ronghai, the head of the Department of Corrections of the Korean Ministry of Justice, said in response to relevant questions that "there is no abnormality in physical condition." (World Wide Web)Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.